ARCHIVES

DCCP Board Approves Concepts For Nearly $20 Million In Grants, Contracts, Including New Inhibitors Study

This article is from The Cancer Letter archive.

Vol. 09 No. 23 | June 10, 1983

Download PDF Visit The Full Archive

Related Articles

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

NCI, USSR Agree On New Collaborative Cancer Control Studies

June 20, 1975

Shubik Subcommittee Criticizes New Study Section, Asks NCI To Hire More Epidemiologists

December 5, 1975

HRT Doesn’t Raise Cancer Risk Following Oophorectomy

October 28, 2005

George Sledge Jr. Named Oncology Chief at Stanford University

October 12, 2012

DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year

May 12, 1978